UBS Group’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

UBS Group’s Portfolio TPI Stock Details TPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,132	Closed	-$1K	–	8321
2016 Q1	$1K	Sell	5,132 -3,263	-39%	-$434	﹤0.01%	7538
2015 Q4	$1K	Buy	8,395 +4,629	+123%	+$1.01K	﹤0.01%	8250
2015 Q3	$1K	Sell	3,766 -1,233	-25%	-$373	﹤0.01%	8311
2015 Q2	$2K	Sell	4,999 -1,705	-25%	-$779	﹤0.01%	8261
2015 Q1	$3K	Buy	+6,704	New	+$3.8K	﹤0.01%	8393

Other funds holding TPI

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CHP

Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return

UBS Group's TPI Position: Q2 2016 in Review

UBS Group sold out of TIANYIN PHARMACEUTICAL (TPI) in Q2 2016, closing a stake of 5,132 shares — an estimated $1K sold.

UBS Group first reported a position in TPI in Q1 2015 and held it in 5 quarters. The position peaked at $3K in Q1 2015. 2 funds tracked by Wall St. Rank hold TPI as of Q2 2016.

UBS Group reported no remaining TIANYIN PHARMACEUTICAL position as of Q2 2016 after selling out during the quarter.
UBS Group sold 5,132 TIANYIN PHARMACEUTICAL shares in Q2 2016, an estimated $1K.
UBS Group first reported a position in TIANYIN PHARMACEUTICAL in Q1 2015 and held it in 5 quarters.
UBS Group's TIANYIN PHARMACEUTICAL position peaked at $3K in Q1 2015.
2 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q2 2016.

Based on UBS Group's 13F filing for Q2 2016, filed 12 Aug 2016.